Stephen Knowles
Chief Executive Officer chez Vector Networks, Inc.
Profil
Stephen Knowles is currently the Chief Executive Officer & Secretary at Vector Networks, Inc. He previously worked as a Director at OSI Pharmaceuticals, Inc. and as a Treasurer & Director at Astellas Institute for Regenerative Medicine.
Postes actifs de Stephen Knowles
| Sociétés | Poste | Début |
|---|---|---|
Vector Networks, Inc.
 Vector Networks, Inc. Packaged SoftwareTechnology Services Vector Networks, Inc. provides desktop management software services. It offers saleable desktop management software and information technology asset management software. The company's services include software, hardware inventory, web-based help desk software, and personnel computer remote control software. The company was founded in 1992 and headquartered in Atlanta, GA. | Chief Executive Officer | - |
Anciens postes connus de Stephen Knowles
| Sociétés | Poste | Fin |
|---|---|---|
| OCATA THERAPEUTICS INC | Director/Board Member | - |
| OSI PHARMACEUTICALS, INC. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
Vector Networks, Inc.
Vector Networks, Inc. Packaged SoftwareTechnology Services Vector Networks, Inc. provides desktop management software services. It offers saleable desktop management software and information technology asset management software. The company's services include software, hardware inventory, web-based help desk software, and personnel computer remote control software. The company was founded in 1992 and headquartered in Atlanta, GA. | Technology Services |
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
